Monday, October 5, 2009

Fmr InterMune Inc. Chief Convicted of Fraud

According to The Associated Press, a federal jury in San Francisco convicted Dr. W. Scott Harkonen after a seven-week trial. The conviction centered on an August 2002 news release that misstated the results of a clinical trial using Actimmune to treat the disease. The release falsely said the test showed Actimmune helped IPF patients live longer.

Treating one IPF patient with Actimmune for a year cost about $50,000, and most Actimmune sales were for the unapproved treatment of IPF, the Justice Department said.

For more information about the case, please click here.

Share this article with your social network, just click below to share now!

No comments: